Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders

NCT04295681 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Cognitive Disorders

Interventions

DRUG: MMH-MAP
DRUG: Placebo

Sponsor

Materia Medica Holding